March 17 (Reuters) - CK Life Sciences Intl (Holdings) Inc
0775.HK :
* FY PROFIT ATTRIBUTABLE HK$182 MILLION, DOWN 31%
* RECOMMENDED A FINAL DIVIDEND OF HK$0.01 PER SHARE FOR YEAR
ENDED
31 DECEMBER 2019
* PROPOSES A FINAL DIVIDEND OF HK$0.01 PER SHARE FOR YEAR
ENDED 31
DEC 2019
* GIVEN DYNAMIC NATURE OF COVID-19 OUTBREAK NOT PRACTICABLE
TO
PROVIDE ESTIMATE OF IMPACTS FINANCIAL POSITION
* FY REVENUE HK$4.97BLN VERSUS HK$5.23 BILLION
* NOT PRACTICABLE TO PROVIDE REASONABLE ESTIMATE OF COVID
IMPACTS
ON GROUP'S FINANCIAL POSITION
Source text for Eikon: urn:newsml:reuters.com:*:nHKSjpC84
Further company coverage: 0775.HK
((Reuters.Briefs@thomsonreuters.com;))